GregoryRNeagosMD
Pulmonology • Grand Rapids, MIAsthma & COPD, Interstitial Lung Diseases
Associate Chief Clinical Officer for Specialty Medicine
Dr. Neagos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2122 Health Dr SW
Ste 220
Grand Rapids, MI 49519Phone+1 616-252-5220Fax+1 616-252-5770- Is this information wrong?
Education & Training
University of Michigan Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992- University of Michigan Health SystemResidency, Internal Medicine, 1986 - 1989
Wayne State University School of MedicineClass of 1986
Certifications & Licensure
MI State Medical License 1988 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Outstanding Teaching Award, Transitional Medicine Residency Class St, Joseph Mercy Hospital, 1997, 2000, 2002, 2006
- William B. Taylor Distinguished Clinical Teacher of the Year Internal Medicine Residency Class, St. Joseph Mercy Hospital, 1996, 2000
- Surgery Chief Residents Appreciation Award Surgical Residency Program, St, Joseph Mercy Hospital, 1998
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsControl of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).Honn Kv, Meyer J, Neagos G, Henderson T, Westley C, Ratanatharathorn> ;Progress in Clinical and Biological Research. 1982 Jan 1
- 13 citationsA review of prostaglandins and the treatment of tumor metastasis.Kenneth V. Honn, David G Menter, Philip G. Cavanaugh, G. Neagos, D. Moilanen, J. D. Taylor, Bonnie F. Sloane> ;Acta Clinica Belgica. 1983 Jan 1
- 13 citationsPhospholipase A2 in alveolar type II epithelial cells: biochemical and immunologic characterization.G. R. Neagos, A. Feyssa, Marc Peters-Golden> ;The American Journal of Physiology. 1993 Mar 1
- Join now to see all
Committees
- Voting member, Medical Executive Committee 2019 - Present
- Voting member, Credentials Committee 2019 - Present
- Board of Directors, The FACES Foundation 2006 - Present
- Physician Leader, St. Joseph Mercy Hospital, Keystone ICU Project 2004 - 2009
- Chairman, Critical Care Committee, St. Joseph Mercy Hospital 2002 - 2009
- Medical Director, Medical Intensive Care Unit, St. Jospeh Mercy Hospital 1995 - 2009
- Medical Director, Respiratory Care, St. Joseph Mercy Hospital 1994 - 2009
Research History
- Co-InvestigatorCOMET, Study of Inhaled rhDNAase in COPD. A Phase III Multinational, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of an Aerosolized Recombinant Human Deoxyribonuclease in Hospital patients with COPD experiencing a Pulmonary Exacerbation. St. Joseph Mercy1995 - 1995
- Co-InvestigatorPhase III, Randomized, Parallel Group, Double-blind Clinical Trial comparing Amiloride Hydrochloride with Placebo in Adolescent and Adult Patients with Cystic Fibrosis. University of Michigan Medical Center.1991 - 1994
Professional Memberships
- Member
- Member
Hospital Affiliations
University of Michigan Health - WestWyoming, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
